Lightnews — Scholar-powered news

Reposted by Memorial Sloan Kettering Cancer Center

Benjamin D. Greenbaum @bengrbm.bsky.social · 4d

Thank you @mskcancercenter.bsky.social for highlighting our work on #viralmimicry in our genome, its evolution, the selective forces on it, and its potential role in cancer.

A great years long collaborative effort with @petrsulc.bsky.social, @daniel-decarvalho.bsky.social, & many great colleagues!

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 4d

Dr. @bengrbm.bsky.social has tried to shed light on the innate immune system and how it affects cancer cells as they evolve.

Now Dr. Greenbaum’s lab has been taking a deep dive into modeling viral mimicry, trying to understand how this could shape cancer cells’ development process. bit.ly/3VWadA8

1 3 13

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 4d

MSK computer scientists and radiation oncologists have developed #AI models to make #radiation therapy safer and more effective — helping to spare healthy tissue and make decisions about needed changes to treatment faster. Learn more: bit.ly/3KE8tcl

How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artiﬁcial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the ...

www.mskcc.org

1

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 4d

Dr. @bengrbm.bsky.social has tried to shed light on the innate immune system and how it affects cancer cells as they evolve.

Now Dr. Greenbaum’s lab has been taking a deep dive into modeling viral mimicry, trying to understand how this could shape cancer cells’ development process. bit.ly/3VWadA8

3

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 5d

Congratulations to MSK's most recent Awards & Appointments honorees, including Dr. Maria Jasin for being awarded the 2025 Peral Meister Greengard Prize, MSK being named one of the World’s Best Specialized Hospitals by @newsweek.com, and more ⬇️

MSK Awards and Appointments September 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Maria Jasin Awarded the 2025 Peral Meister Greengard Prize

www.mskcc.org

Reposted by Memorial Sloan Kettering Cancer Center

Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 6d

What a fantastic day of learning courtesy of @mskcme.bsky.social @mskcancercenter.bsky.social !
Can’t wait for tomorrow’s sessions!
Thank you @billyrosaphd.bsky.social & your planning team 🎉!

1 2 3

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 6d

New from MSK: A team co-led by Dr. Talya Salz and Dr. Thomas Atkinson are studying how an algorithm guided by a large language model could help identify themes related to the experience of #cancer pain from narrative reports. Learn more: www.mskcc.org/news/msk-res...

Reposted by Memorial Sloan Kettering Cancer Center

Asier Antoñana @antonanaasier.bsky.social · 10d

Big news! 🚀 I’m joining MSK as a Postdoctoral Fellow in the Balachandran Lab!
🔬I’ll focus on tumor immunology in pancreatic cancer—harnessing the immune system to advance future therapies. Looking forward to growing with MSK’s research community!

@mskcancercenter.bsky.social

1 5

Reposted by Memorial Sloan Kettering Cancer Center

Urvi Shah, MD, MS @urvishahmd.bsky.social · 10d

Krisstina Gowin and I discuss the importance of patient-centered wellness interventions in the field of hematology @ashclinicalnews.bsky.social
@ash.hematology.org
@mskcancercenter.bsky.social
@cityofhope.bsky.social

ashpublications.org/ashclinicaln...

#mmsm #lymsm #bmtsm #leusm

Bridging the Gap: How Hematology Can Better Support Patient Wellness | ASH Clinical News | American Society of Hematology

ashpublications.org

1 4

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 10d

MSK's Dr. Nancy Lee presented updated results at the Annual Meeting of @astro-org.bsky.social confirming that the addition of pembrolizumab to standard of care improved event-free survival for people with locally advanced #HNSCC.

bit.ly/48LfqlI

Pembrolizumab for Locally Advanced Head and Neck Squamous Cell Carcinoma Approved by the FDA for Use Before and After Surgery

Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.

bit.ly

1

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 11d

At this year's @astro-org.bsky.social conference, MSK experts shared their work in more than 60 presentations & poster sessions.

The presentations included two clinical trials that looked at the benefits & effects of lowering #radiation doses. Check out more highlights from the #ASTRO25 conference:

ASTRO 2025 Highlights From MSK

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.

www.mskcc.org

2

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 11d

(2/2) “Until this study, prospective evidence comparing proton beam radiotherapy with IMRT for this patient population had been lacking,” says MSK's Dr. Nancy Lee. “Importantly, our study included patient-reported outcomes as clinician grading alone tends to underestimate symptom burden.”

MSK ASTRO 2025 News: Proton Beam Radiotherapy is Superior to Photon Beam Radiotherapy in Head and Neck Cancer

Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy in patients with head and neck cancers, according to resul...

www.mskcc.org

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 11d

(1/2) Presented at #ASTRO25: Results from a MSK-led clinical trial show that #protonbeam radiotherapy resulted in similar oncologic outcomes w/ less toxicity and improved quality of life than #photonbeam radiotherapy (intensity modulated #radiotherapy, IMRT) in patients w/ head and neck cancers.

1

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 12d

Coming up at #ASTRO25: MSK’s Dr. Nancy Lee will discuss #neoadjuvant and #adjuvant pembrolizumab plus standard of care in resectable locally advanced head and neck squamous cell #carcinoma. @astro-org.bsky.social

Tuesday, 9/30 | 2:30 p.m. PDT

Learn more: bit.ly/4pNSt7K

1

Reposted by Memorial Sloan Kettering Cancer Center

Stand Up To Cancer @su2c.bsky.social · 12d

Cancer research saves lives. Dan Tukey is a survivor today thanks to the treatment he received in a colorectal cancer clinical trial funded by #StandUpToCancer. Help push cancer research further at StandUpToCancer.org. ❤️

@mskcancercenter.bsky.social

1 3

Reposted by Memorial Sloan Kettering Cancer Center

Linda B. Rosenthal @lindabrosenthal.bsky.social · 12d

Undergoing chemotherapy doesn’t mean you have to lose your hair or identity.

Honored to celebrate the passage of my first-in-the-nation law with Senator Stavisky requiring insurance carriers to cover the cost of scalp cooling at @mskcancercenter.bsky.social. 🎉

1 2

Reposted by Memorial Sloan Kettering Cancer Center

MSKEducation @mskeducation.bsky.social · 12d

To all #MSKPostdocs - THANK YOU!
Your contributions are vital to the @mskcancercenter.bsky.social research community.
We are proud to celebrate you during #NPAW2025 and every day of the year! 👏🧪💙

National Postdoc Appreciation Week
September 2025

1 4

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 12d

MSK Kids, the pediatric cancer program at MSK, has one of the nation’s largest teams dedicated to neuroblastoma and treats more children w/ this cancer than any other center in the U.S.

Learn more about the latest clinical & molecular research advances for patients w/ high-risk #neuroblastoma.

MSK Kids: Recent Research Advances for High-Risk Neuroblastoma

MSK Kids is continuously investigating new ways to improve outcomes and the quality of life for pediatric patients with high-risk neuroblastoma. In this article we detail highlights of the latest clin...

www.mskcc.org

Reposted by Memorial Sloan Kettering Cancer Center

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 13d

Rockstar #radonc @mskcancercenter.bsky.social resident Dr Kaitlyn Lapen presents at #ASTRO25 on quality of life improvements with early radiation for asymptomatic bone metastasis which may appear after 6 months. Optimal patient selection is key. @astro-org.bsky.social

Conclusions
• From phase Il primary study, early RT reduces SRE (30% vs. 2%)
• More work needed to better predict SRE
• Early RT may preserve self-care and functional ability compared to observation
• Benefits emerge after about six months
• Consider prognosis
• Patient-reported outcomes provide insightful and hypothesis-generating findings
• Confirmatory Phase Ill randomized controlled trial (NRG-CC014, PREEMPT) is ongoing
• Has enrolled 48/280 patients
ASTRO 67TH ANNUAL MEETING | September 27 - October 1, 2025

3 6

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 13d

Up next at #ASTRO25: MSK’s Dr. Alexander Goglia will discuss the impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Follow along for coverage of the latest advances.

Monday, 9/29 | 10:45 a.m. PDT

Learn more: bit.ly/483tNla

3

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 13d

Up next at #ASTRO25: MSK’s Dr. Alexander Goglia will discuss the impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Follow along for coverage of the latest advances.

Monday, 9/29 | 10:45 a.m. PDT

Learn more: bit.ly/483tNla

2

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 13d

Up next at #ASTRO25: MSK’s Dr. Alok Deshane will discuss TP53 mutations and outcomes after #radiotherapy in mantle cell #ymphoma. Follow along for coverage of the latest advances.

Monday, 9/29 | 10:45 a.m. PDT

Learn more: bit.ly/3W8iq43

1

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 17d

“These results will change how many breast cancers are treated." Learn more:

FDA Approves Imlunestrant to Stop Progression of ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.

www.mskcc.org

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 18d

Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️

The Latest Radiation Therapy for Prostate Cancer: What Every Man Should Know

It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.

www.mskcc.org

2 3

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 18d

Cancer research means bigger breakthroughs, on a faster timeline, that improve the lives of people impacted by cancer. Today is World Cancer Research Day & all donations will be DOUBLED.

Donate today & help bring more possibilities to families facing cancer. bit.ly/46mefYy #WorldCancerResearchDay

1 5

Reposted by Memorial Sloan Kettering Cancer Center

Journal of Cell Biology @jcb.org · 20d

ATG16L strikes again! New findings link #lysosome stress and physiology. Alison Klein and Michael Overholtzer @mskcancercenter.bsky.social discuss new study from @thabataduque.bsky.social et al. of the Deretic group (rupress.org/jcb/article/...) in Spotlight: rupress.org/jcb/article/...

4 5